fep blue glp-1 coverage 2026 Bad News re: BCBS (Federal Employee Program, FEPBlue) Who Gets the Shot? GLP-1

Subsequently, things changed rapidly

Reduced Nutrient Intake Because GLP-1 medications suppress appetite, some individuals consume fewer calories and less protein than the body requires for normal hair production

Nearly half of GLP-1 prescriptions are denied on the first try even for qualifying patients

Moreover, weight gain and peripheral edema are well-known side effects of TZD, which may limit the role of TZD in the treatment of patients with NAFLD

Front Mol Biosci

Lixisenatide In the ELIXA (Evaluation of Lixisenatide in Acute Coronary Syndrome) study, T2D patients with a recent coronary artery event were randomly assigned (1:1) to a lixisenatide (1020 g) group or placebo group (Pfeffer et al., 2015)